PMS5 PERSISTENCE WITH BISPHOSPHONATE THERAPY AND RISK OF HIP FRACTURE (original) (raw)
Related papers
Gastroenterology, 2010
Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors
Pharmacotherapy, 2008
Fracture Incidence and Characterization in Patients on Osteoporosis Treatment: The ICARO Study
Journal of Bone and Mineral Research, 2006
Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals
Bone, 2013
Use of proton pump inhibitors and risk of osteoporosis-related fractures
Canadian Medical Association Journal, 2008
Proton pump inhibitors and fracture risk. The HUNT study, Norway
Osteoporosis International, 2019
Osteoporosis International, 2021
The Association Between Prolonged Proton Pump Inhibitors Use and Bone Mineral Density
Risk Management and Healthcare Policy
Therapeutics and Clinical Risk Management, 2011
Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis
Journal of Bone Metabolism, 2018
Proton-pump inhibitor use and hip fractures in men: a population-based case-control study
Annals of Epidemiology, 2014
Osteoporosis International, 2010
Use of proton pump inhibitors and mortality after hip fracture in a nationwide study
Osteoporosis International, 2017
Osteoporosis International, 2010
F1000 - Post-publication peer review of the biomedical literature
Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date
2002
Bisphosphonate use and hip fracture epidemiology: ecologic proof from the contrary
2010
Proton pump inhibitors use and change in bone mineral density
International Journal of Rheumatic Diseases, 2016
Osteoporosis treatment and fracture incidence: the ICARO longitudinal study
Osteoporosis International, 2008
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Patient Preference and Adherence, 2008
BMC Musculoskeletal Disorders, 2007
Concerns on Medications Used in Osteoporosis
Journal of Clinical Rheumatology and Immunology
Long-Term Oral Bisphosphonate Therapy and Fractures in Older Women: The Women's Health Initiative
Journal of the American Geriatrics Society, 2017
Long-term impact of adherence to oral bisphosphonates on osteoporotic fracture incidence
Journal of Bone and Mineral Research, 2011
Drug-Related Adverse Events of Osteoporosis Therapy
Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004
The Journal of rheumatology, 2008
Bone, 2013
Osteoporosis medication and reduced mortality risk in elderly women and men
2011
PLOS ONE, 2015
CMAJ open, 2013
Bone, 2013